KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbCellera Biologics (ABCL) Change in Account Payables (2020 - 2024)

AbCellera Biologics' Change in Account Payables history spans 5 years, with the latest figure at $130000.0 for Q3 2024.

  • For the quarter ending Q3 2024, Change in Account Payables fell 86.67% year-over-year to $130000.0, compared with a TTM value of $975000.0 through Sep 2024, up 125.25%, and an annual FY2022 reading of -$3.2 million, down 325.71% over the prior year.
  • Change in Account Payables for Q3 2024 was $130000.0 at AbCellera Biologics, down from $4.7 million in the prior quarter.
  • The five-year high for Change in Account Payables was $27.9 million in Q4 2021, with the low at -$22.9 million in Q3 2021.
  • Average Change in Account Payables over 5 years is $166055.6, with a median of $741000.0 recorded in 2022.
  • Biggest YoY gain for Change in Account Payables was 653.11% in 2021; the steepest drop was 4473.08% in 2021.
  • Tracing ABCL's Change in Account Payables over 5 years: stood at $3.7 million in 2020, then surged by 653.11% to $27.9 million in 2021, then plummeted by 107.19% to -$2.0 million in 2022, then soared by 148.53% to $975000.0 in 2023, then tumbled by 86.67% to $130000.0 in 2024.
  • Per Business Quant, the three most recent readings for ABCL's Change in Account Payables are $130000.0 (Q3 2024), $4.7 million (Q2 2024), and -$4.9 million (Q1 2024).